Tela Bio, Inc. income statement

In fiscal 2025, Tela Bio, Inc. reported revenue of $80.3m, up 15.8% on the year before, operating income of −$33.8m (a -42.0% margin) and net income of −$38.8m, or −$0.83 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Tela Bio, Inc.: income statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	4	8	15	18	29	41	58	69	80	80
Gross profit	3	3	9	11	19	27	40	46	54	54
Research and development	6	4	4	4	7	9	10	9	9	10
Selling and marketing	9	14	18	22	29	43	60	65	63	63
General and administrative	5	5	6	10	12	14	15	15	16	16
Operating income	−17	−18	−19	−25	−29	−39	−44	−34	−34	−34
Interest expense	5	2	4	4	4	4	5	5	5	7
Income before tax	—	—	—	—	—	−44	−47	−38	−39	−41
Income tax	—	—	—	—	—	—	—	−0	0	0
Net income	−21	−21	−22	−29	−33	−44	−47	−38	−39	−41
Diluted EPS	—	−$101.41	−$17.10	−$2.23	−$2.30	−$2.72	−$2.04	−$1.33	−$0.83	−$0.78
Diluted shares (average)	—	—	2m	13m	14m	16m	23m	29m	47m	53m
EBITDA	−16	−17	−19	−25	−29	−39	−44	−33	−33	−33

US$ millions unless shown otherwise. Fiscal quarters.

Tela Bio, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	19	18	19	20	21	21	19	19
Gross profit	13	11	13	14	14	14	13	14
Research and development	2	2	3	2	2	2	2	3
Selling and marketing	16	14	17	17	15	14	17	16
General and administrative	4	4	4	4	4	4	4	4
Operating income	−9	−8	−10	−9	−8	−7	−11	−9
Interest expense	1	1	1	1	1	2	2	2
Income before tax	−10	−9	−11	−10	−9	−9	−12	−11
Income tax	—	—	0	0	0	0	0	0
Net income	−10	−9	−11	−10	−9	−9	−12	−11
Diluted EPS	−$0.42	−$0.17	−$0.25	−$0.22	−$0.19	−$0.17	−$0.21	−$0.20
EBITDA	−9	−8	−10	−9	−7	−7	−10	−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PDEX vs TELA SGHT vs TELA RCEL vs TELA ELMD vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Tela Bio, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tela Bio, Inc.